Wetzel Investment Advisors, Inc. 89bio, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in 89bio, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 5,000 shares of ETNB stock, worth $46,200. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,000
Previous 3,000
66.67%
Holding current value
$46,200
Previous $34,000
70.59%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
166Shares Held
89.3MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$116 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$68.2 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$61.3 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$58.2 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$51.2 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $430M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...